Literature DB >> 17890408

Autism spectrum disorders in children with a history of infantile spasms: a population-based study.

Evald Saemundsen1, Petur Ludvigsson, Vilhjalmur Rafnsson.   

Abstract

The objective of this article is to describe autistic spectrum disorders in children diagnosed with infantile spasms in the first year of life. The source of data was the records of all 3 pediatric departments in Iceland. Twenty children born between 1981 and 1998 who had infantile spasms were invited to participate. When appropriate, the parents of these children were asked to complete the Social Communication Questionnaire. Children scoring 10 points or higher on the questionnaire were selected for further examination using the Autism Diagnostic Interview- Revised and either the Autism Diagnostic Observation Schedule or the Childhood Autism Rating Scale. All participants were given appropriate cognitive tests or measures of adaptive behavior. The parents of 17 children (10 boys, 7 girls) agreed to participate in the study. Age at assessment ranged from 5 to 19 years with a mean age of 11 years and 6 months. Fourteen children had at least one neurodevelopmental disorder. Six (6/17), or 35.3%, were diagnosed with autism spectrum disorder (3 boys, 3 girls), five of these had a history of symptomatic infantile spasms, and four were profoundly mentally retarded (IQ/DQ<20). If the diagnosis of autism spectrum disorder was restricted to children with a developmental age of 24 months or more (3 cases), the prevalence was 17.6%. The estimates found in this study exceed the estimated prevalence of autism spectrum disorder in the general population.

Entities:  

Mesh:

Year:  2007        PMID: 17890408     DOI: 10.1177/0883073807306251

Source DB:  PubMed          Journal:  J Child Neurol        ISSN: 0883-0738            Impact factor:   1.987


  24 in total

1.  Autism and Cognition Within Epilepsy: Social Matters.

Authors:  Roberto Tuchman
Journal:  Epilepsy Curr       Date:  2015 Jul-Aug       Impact factor: 7.500

2.  In search of epilepsy biomarkers in the immature brain: goals, challenges and strategies.

Authors:  Aristea S Galanopoulou; Solomon L Moshé
Journal:  Biomark Med       Date:  2011-10       Impact factor: 2.851

Review 3.  Epileptic encephalopathies: new genes and new pathways.

Authors:  Sahar Esmaeeli Nieh; Elliott H Sherr
Journal:  Neurotherapeutics       Date:  2014-10       Impact factor: 7.620

4.  Early Identification of Autism: Early Characteristics, Onset of Symptoms, and Diagnostic Stability.

Authors:  Sara Jane Webb; Emily J H Jones
Journal:  Infants Young Child       Date:  2009 Apr-Jun

Review 5.  Infantile Spasms-Have We Made Progress?

Authors:  Sarah Aminoff Kelley; Kelly G Knupp
Journal:  Curr Neurol Neurosci Rep       Date:  2018-04-19       Impact factor: 5.081

Review 6.  Epilepsy and autism: neurodevelopmental perspective.

Authors:  Roberto Tuchman; Michael Cuccaro
Journal:  Curr Neurol Neurosci Rep       Date:  2011-08       Impact factor: 5.081

Review 7.  Cognitive and neurodevelopmental comorbidities in paediatric epilepsy.

Authors:  Katherine C Nickels; Michael J Zaccariello; Lorie D Hamiwka; Elaine C Wirrell
Journal:  Nat Rev Neurol       Date:  2016-07-22       Impact factor: 42.937

Review 8.  Syndromic autism: causes and pathogenetic pathways.

Authors:  Arianna Benvenuto; Romina Moavero; Riccardo Alessandrelli; Barbara Manzi; Paolo Curatolo
Journal:  World J Pediatr       Date:  2009-08-20       Impact factor: 2.764

Review 9.  Prenatal corticosteroids modify glutamatergic and GABAergic synapse genomic fabric: insights from a novel animal model of infantile spasms.

Authors:  D A Iacobas; S Iacobas; T Chachua; C Goletiani; G Sidyelyeva; J Velíšková; L Velíšek
Journal:  J Neuroendocrinol       Date:  2013-11       Impact factor: 3.627

10.  Early life seizures: evidence for chronic deficits linked to autism and intellectual disability across species and models.

Authors:  Paul B Bernard; Tim A Benke
Journal:  Exp Neurol       Date:  2014-10-02       Impact factor: 5.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.